Rijkswet van 30 november 2006 tot wijziging van de Rijksoctrooiwet 1995 ter implementatie van richtlijn nr. 2004/27/EG en richtlijn nr. 2004/28/EG
This Dutch law updates the national patent act to align with two European directives concerning pharmaceutical products. It aims to harmonize patent rules across the EU for medicines. This affects pharmaceutical companies, researchers, and patients by clarifying patent rights and potentially influencing the availability and cost of medicines.
National vote coverage: Netherlands-only